Biotech Values

[jbog]

Dew

I still think Alt has a decent shot in the weight loss field. In hindsight maybe they'll have to try some dose titration similar to NOVO's 5 month period and Lilly's 6 month schedule (both 5 increasing dosages) to bring the side effect's within norm.

Pevidutide looks good in Fatty Liver so far.

I liked the risk reward at $10 so I like it more at $5. Weight loss drugs are going to be a massive market.

From Cathie Woods Today:

Cathie Wood highlighted one silver lining of the brutal run her exchange-traded funds suffered through last year: those billions of dollars in losses will help offset future tax bills on gains.

The founder and chief executive officer of ARK Investment Management told Bloomberg TV Tuesday that she has over $2 billion in losses from selling stocks during the market rout. By selling stocks at a loss, those losses can now lower, and potentially offset the tax bill Wood’s funds could receive on future capital gains.

LOLOL